Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery | |
Song, Kaichao1; Xin, Meng1,2; Yu, Hongxia3; Zheng, Zhou4; Li, Jun5; Li, Mengshuang1,6; Guo, Huimin1; Tan, Youlan1; Wu, Xianggen1 | |
刊名 | INTERNATIONAL JOURNAL OF PHARMACEUTICS |
2018-12 | |
卷号 | 552期号:1-2页码:265-276 |
关键词 | Rebaudioside A Coumarin-6 Micelle Ocular drug delivery |
ISSN号 | 0378-5173 |
DOI | 10.1016/j.ijpharm.2018.10.006 |
英文摘要 | We investigated if the self-assembled micelles of rebaudioside A (RA) could potentially be utilized as an ocular drug-delivery system in this investigation. RA self-assembled into micelles with ultra-small particle sizes ( < 4 nm) in a homogeneous distribution state (polydispersity index < 0.3). RA had good cellular tolerance and no cytotoxicity was observed at concentrations <= 18.5 mg/ml at 72 h of incubation. RA also did not cause cell apoptosis at concentration <= 12 mg/ml. Coumarin-6 (Cou6)-loaded RA micelles had good cellular tolerance and in vivo non-irritants to the rabbit eyes. RA micelles dramatically improved the cellular uptake of Cou6 (compared to free-Cou6 P < 0.05); an energy-independent, active, intracellular endocytosis pathway was apparently involved, and cellular organelles such as lysosomes, endoplasmic reticuli, and mitochondria were observed with a high distribution of Cou6, while a much more sophisticated endocytosis pathway was apparently involved in the ex vivo corneal endocytosis mechanism tests. The use of RA micelles significantly improved in vivo corneal permeation of the encapsulated Cou6 when compared to free-Cou6 eye drops (P < 0.05). These findings indicate that RA micelle formulations have great potential as a novel ocular drug-delivery system to improve the bioavailability of hydrophobic drugs. |
资助项目 | Project of Medical and Health Technology Development Program in Shandong Province, China[2017WS633] |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | ELSEVIER SCIENCE BV |
WOS记录号 | WOS:000447985800030 |
内容类型 | 期刊论文 |
源URL | [http://ir.fio.com.cn/handle/2SI8HI0U/2758] |
专题 | 业务部门_海洋生态研究中心 |
作者单位 | 1.Qingdao Univ Sci & Technol, Coll Chem Engn, Dept Pharm, Qingdao 266042, Peoples R China; 2.Binshou Med Univ, Yantai Affiliated Hosp, Dept Ophthalmol, Yantai 264100, Peoples R China; 3.Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao 266021, Peoples R China; 4.State Ocean Adm, Inst Oceanog 1, Key Lab Marine Bioact Subst, Qingdao 266061, Peoples R China; 5.Shandong Acad Med Sci, Shandong Eye Inst, Qingdao Eye Hosp, Qingdao 266071, Peoples R China; 6.Qingdao Women & Childrens Hosp, Pharm Intravenous Admixture Serv, Qingdao 266034, Peoples R China |
推荐引用方式 GB/T 7714 | Song, Kaichao,Xin, Meng,Yu, Hongxia,et al. Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS,2018,552(1-2):265-276. |
APA | Song, Kaichao.,Xin, Meng.,Yu, Hongxia.,Zheng, Zhou.,Li, Jun.,...&Wu, Xianggen.(2018).Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery.INTERNATIONAL JOURNAL OF PHARMACEUTICS,552(1-2),265-276. |
MLA | Song, Kaichao,et al."Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery".INTERNATIONAL JOURNAL OF PHARMACEUTICS 552.1-2(2018):265-276. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论